Zhuoan Cheng

2.6k total citations · 1 hit paper
21 papers, 1.6k citations indexed

About

Zhuoan Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhuoan Cheng has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Zhuoan Cheng's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Zhuoan Cheng is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Zhuoan Cheng collaborates with scholars based in China and Ethiopia. Zhuoan Cheng's co-authors include Wenxin Qin, Liyan Jiang, Cun Wang, Haojie Jin, Chengtao Yu, Qiaozhu Zuo, Shaohua Cui, Yuanyuan Lv, Botai Li and Siying Wang and has published in prestigious journals such as Nature Communications, Hepatology and Cancer Letters.

In The Last Decade

Zhuoan Cheng

21 papers receiving 1.6k citations

Hit Papers

circNDUFB2 inhibits non-small cell lung cancer progressio... 2021 2026 2022 2024 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhuoan Cheng China 17 1.3k 1.1k 130 109 97 21 1.6k
Danilo Fiore Italy 16 898 0.7× 776 0.7× 225 1.7× 216 2.0× 105 1.1× 26 1.5k
Xiaotian Shen China 11 639 0.5× 486 0.5× 121 0.9× 125 1.1× 162 1.7× 20 1.0k
Xiaobin Lv China 17 1.6k 1.2× 1.5k 1.4× 92 0.7× 189 1.7× 130 1.3× 31 1.9k
Annette Rempel Germany 12 942 0.7× 826 0.8× 86 0.7× 187 1.7× 40 0.4× 13 1.3k
Yang Zheng China 17 782 0.6× 438 0.4× 92 0.7× 144 1.3× 241 2.5× 51 1.2k
Luke Miller United States 6 699 0.5× 500 0.5× 114 0.9× 261 2.4× 46 0.5× 8 963
Yang-Hsiang Lin Taiwan 24 834 0.7× 683 0.6× 161 1.2× 193 1.8× 101 1.0× 59 1.3k

Countries citing papers authored by Zhuoan Cheng

Since Specialization
Citations

This map shows the geographic impact of Zhuoan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuoan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuoan Cheng more than expected).

Fields of papers citing papers by Zhuoan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuoan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuoan Cheng. The network helps show where Zhuoan Cheng may publish in the future.

Co-authorship network of co-authors of Zhuoan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuoan Cheng. A scholar is included among the top collaborators of Zhuoan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuoan Cheng. Zhuoan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Zhuoan, Chunlai Lu, Hui Wang, et al.. (2022). Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression. Cancer Letters. 531. 1–13. 30 indexed citations
2.
Yang, Chen, Zhuoan Cheng, Zhicheng Liu, et al.. (2022). Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer. Genome Medicine. 14(1). 142–142. 19 indexed citations
3.
Li, Botai, Lili Zhu, Chunlai Lu, et al.. (2021). circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nature Communications. 12(1). 295–295. 416 indexed citations breakdown →
4.
Yu, Chengtao, Zhuoan Cheng, Shaohua Cui, et al.. (2020). circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D. Journal of Experimental & Clinical Cancer Research. 39(1). 55–55. 41 indexed citations
5.
He, Jia, Qiaozhu Zuo, Bo Hu, et al.. (2019). A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Letters. 450. 98–109. 98 indexed citations
6.
Yang, Chen, Siying Wang, Haoyu Ruan, et al.. (2019). Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma. Journal of Cancer. 10(4). 918–926. 37 indexed citations
7.
Tao, Xuemei, Qiaozhu Zuo, Haoyu Ruan, et al.. (2019). Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma. Acta Biochimica et Biophysica Sinica. 51(3). 263–276. 27 indexed citations
8.
Cheng, Zhuoan, Chengtao Yu, Shaohua Cui, et al.. (2019). circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nature Communications. 10(1). 3200–3200. 284 indexed citations
9.
Cui, Shaohua, Zhuoan Cheng, Wenxin Qin, & Liyan Jiang. (2017). Exosomes as a liquid biopsy for lung cancer. Lung Cancer. 116. 46–54. 138 indexed citations
10.
Ge, Zhouhong, Zhuoan Cheng, Xin‐Rong Yang, et al.. (2017). Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma. Cancer Science. 108(4). 653–662. 41 indexed citations
11.
Tang, Qingfeng, Zhenhua Ni, Zhuoan Cheng, et al.. (2015). Three Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting NSCLC. Cellular Physiology and Biochemistry. 37(3). 1002–1009. 64 indexed citations
12.
Cai, Jianhua, et al.. (2015). Xiayuxue decoction reduces renal injury by promoting macrophage apoptosis in hepatic cirrhotic rats. Genetics and Molecular Research. 14(3). 10760–10773. 5 indexed citations
13.
15.
Liu, Cheng, et al.. (2015). Paeoniflorin exerts a nephroprotective effect on concanavalin A-induced damage through inhibition of macrophage infiltration. Diagnostic Pathology. 10(1). 120–120. 20 indexed citations
16.
Zhang, Xuemei, Hao Wang, Yunman Wang, et al.. (2013). Vasomotor Dysfunction in the Mesenteric Artery after Organ Culture with Cyclosporin A. Basic & Clinical Pharmacology & Toxicology. 113(6). 370–376. 5 indexed citations
17.
Wang, Ziyuan, Xin Liang, Zhuoan Cheng, et al.. (2013). Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells. Anti-Cancer Drugs. 24(4). 355–365. 5 indexed citations
18.
Zheng, Yuanhong, Vanminh Le, Zhuoan Cheng, et al.. (2012). Development of rapid and highly sensitive HSPA1A promoter-driven luciferase reporter system for assessing oxidative stress associated with low-dose photodynamic therapy. Cell Stress and Chaperones. 18(2). 203–213. 21 indexed citations
19.
Cheng, Zhuoan, et al.. (2012). MiR-320a is Downregulated in Patients with Myasthenia Gravis and Modulates Inflammatory Cytokines Production by Targeting Mitogen-activated Protein Kinase 1. Journal of Clinical Immunology. 33(3). 567–576. 66 indexed citations
20.
Jiang, Lin, Zhuoan Cheng, Shaobo Qiu, et al.. (2012). Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells. International Immunopharmacology. 14(2). 217–223. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026